Limiting AAA With Metformin (LIMIT) Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 314 participants.
Also called NCT04500756
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 314 participants
- Registry
-
NCT04500756
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04500756. Randomized; triple masking; primary purpose treatment. Start 2022-02-28 (actual); primary completion 2028-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Limiting AAA With Metformin (LIMIT) Trial
- Acronym
- LIMIT
- Condition
- Abdominal Aortic Aneurysm
- Intervention (Drug)
- Metformin
- Intervention (Other)
- Placebo
- Lead sponsor
- Stanford University
- Collaborator
- Kaiser Permanente
- Collaborator
- VA Palo Alto Health Care System
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct04500756- Content hash
43b58f85fd8d20baf8d06e20c5e4d2da6237cfbc2157554bedd4e005a2009fc6